175.4 lbs P 96 BP 137/78 RR 16 T 97 %O2 Sat 96 Gen- NAD Chest- CTAB, no wheezes or rales Heart- RRR, nl S1S2, no M/G/R Abd- soft, NTND, +BS Ext- warm, no C/C/E  Pertinent Results: [**2115-4-23**] calcHCT-32  Pathology Examination SPECIMEN SUBMITTED: Esophageal Gastrectomy Specimen, SPLEEN, PARA ESOPHAGEAL LYMPH NODE & SUBCARINAL LYMPH NODE.
The total length of esophagus measures 24 cm.
Cardiology Report ECHO Study Date of [**2115-5-3**] MEASUREMENTS: Left Atrium - Long Axis Dimension: *4.2 cm (nl <= 4.0 cm) Left Ventricle - Septal Wall Thickness: *1.2 cm (nl 0.6 - 1.1 cm) Left Ventricle - Inferolateral Thickness: *1.2 cm (nl 0.6 - 1.1 cm) Left Ventricle - Diastolic Dimension: 5.5 cm (nl <= 5.6 cm) Left Ventricle - Systolic Dimension: 3.7 cm Left Ventricle - Fractional Shortening: 0.33 (nl >= 0.29) Left Ventricle - Ejection Fraction: >= 65% (nl >=55%) Aorta - Valve Level: 3.6 cm (nl <= 3.6 cm) Aorta - Ascending: 3.2 cm (nl <= 3.4 cm) Aortic Valve - Peak Velocity: 1.3 m/sec (nl <= 2.0 m/sec) Mitral Valve - E Wave: 0.6 m/sec Mitral Valve - A Wave: 0.9 m/sec Mitral Valve - E/A Ratio: 0.67 Mitral Valve - E Wave Deceleration Time: 151 msec  INTERPRETATION: Findings: LEFT ATRIUM: Mild LA enlargement.
GENERAL COMMENTS: Suboptimal image quality - poor echo windows.
On POD 16 he passed his bedside swallow evaluation for pureed foods and nectar thick liquids.
His INR was therapeutic on warfarin (given for paroxysmal afib, pt currently in sinus rhythm, goal INR 2.0) and the heparin drip was discontinued.
PCP: [**Name10 (NameIs) **],[**Name11 (NameIs) **] [**Name Initial (NameIs) **].
